Skip to main content
×
Login
Submit a Manuscript
Home
Journal
Current Issue
Archive
For Authors
Column Series
Research & Insight
Special Reports
Subscribe
Resources
Blogs
Expert Insights
Latest News
Pathways Beyond Oncology
Topics
Comparative Effectiveness Research
Cost-Effectiveness Research
COVID-19 Updates
Guideline Updates
Health Economics and Outcomes Research
Health Technology
Real-World Data
Reimbursement
Value-Based Care
Specialties
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
B-Cell Lymphoma
Biosimilars
Bladder Cancer
Breast Cancer
CAR-T Therapies
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Colorectal Cancer
Diffuse Large B-Cell Lymphoma
Follicular Lymphoma
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Head and Neck Cancer
Immuno-Oncology
Kidney Cancer
Liver Cancer
Lung Cancer
Mantle Cell Lymphoma
Melanoma
Multiple Myeloma
Non-Small Cell Lung Cancer
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Skin Cancer
Supportive Care
Excellence Forums
Mantle Cell Lymphoma Excellence Forum
Conferences
Oncology Clinical Pathways Congress
ASCO Gastrointestinal Cancers Symposium
ACCC Annual Meeting & Cancer Center Business Summit
ASCO Genitourinary Cancers Symposium
ASH Annual Meeting and Exposition
Oncology CME
About
About Us
Contact
Mantle Cell Lymphoma Excellence Forum
Videos
Calquence Confidence (Sponsored)
February 11, 2021
Videos
Physician Testimonial With Dr. Goy (Sponsored)
February 11, 2021
Andre Goy, MD, discusses the use of acalabrutinib for the treatment of patients with MCL.
Podcast
Real-World Practice Patterns and Predictors of Survival in Older Patients With MCL
January 15, 2021
David Bond, MD, discusses real-world clinical outcomes and predictors of survival in older patients with MCL treated in the rituximab era.
Podcast
Novel BTK Inhibitor Promising for Mantle Cell Lymphoma
June 23, 2020
Peter Martin, MD, Weill Cornell Medicine, discusses the data that led to the recent accelerated approval of zanubrutinib for the treatment of patients with mantle cell lymphoma.
Stay in the know.
Journal of Clinical Pathways Newsletter
Back to Top